Amir Hossein Miri, M.D, Ph.D
Researcher, Pharmaceutical Biomaterials
Tehran University of Medical Sciences, Iran
[Read Interview session with Amir Hossein Miri]
Miri AH, Kamankesh M, Llopis-Lorente A, et al. The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Front Pharmacol. 2022;13:917184
Miri AH, Kamankesh M, Rad-Malekshahi M, et al. Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal against Helicobacter pylori. Expert Rev Anti Infect Ther. 2023;21:617-639
Kamankesh M, Yadegar A, Llopis-Lorente A, et al. Future nanotechnology-based strategies for improved management of Helicobacter pylori infection. Small. 2024;20(3):e2302532. doi: 10. 1002/smll.202302532
ORCID: |
0000-0003-4740-1699 |
ResearchGate: |
https://www.researchgate.net/profile/Amir-Hossein-Miri |
Google Scholar: |
https://scholar.google.com/citations?user=omrtDHYAAAAJ&hl=en |
1- Antibiotics
2- Antibiotic Resistance
3-Gastrointestinal microbiota
4- Helicobacter pylori
5- Nanoparticles
6- Pharmaceutical formulations
7-Co-solvency techniques